Jiuyuan Yinhai(SZ:002777) Huachuang Securities·2025-05-20 10:35Investment Rating - The report maintains a "Recommendation" rating for the company, with a target price of 22.8 yuan [2][9]. Core Views - The company achieved a revenue of 1.339 billion yuan in 2024, a slight decline of 0.55% year-on-year, and a net profit attributable to shareholders of 73 million yuan, down 55.96% year-on-year. In Q1 2025, revenue increased to 208 million yuan, a growth of 6.25% year-on-year, with a net profit of 15 million yuan, up 17.18% year-on-year [2][9]. - The company is steadily advancing in smart healthcare and actively laying out data elements, with a focus on developing integrated solutions for smart hospitals and healthcare systems [9]. - The company has established partnerships with various data operation units to promote the implementation of data elements in the market, leveraging public data resources to create a comprehensive solution and technical system [9]. Financial Summary - For 2024, total revenue is projected at 1.339 billion yuan, with a year-on-year growth rate of -0.5%. By 2025, revenue is expected to rise to 1.487 billion yuan, reflecting an 11% growth rate [4]. - The net profit attributable to shareholders is forecasted to be 73 million yuan in 2024, with a significant recovery to 154 million yuan in 2025, indicating a growth rate of 110.2% [4]. - The company's earnings per share (EPS) is expected to increase from 0.18 yuan in 2024 to 0.38 yuan in 2025, with a projected price-to-earnings (P/E) ratio of 60x for 2025 [4][9].